USA-based Vidacare's EZ-IO product system, the market-leading solution for immediate vascular access when conventional IV access is challenging or impossible, has been launched in the UK.
As part of the move, the San Antonio, Texas-based firm will also open a UK office, its first outside the USA, which will serve as its hub for all sales of EZ-IO to hospitals and emergency services throughout Britain.
The firm noted that the EZ-IO provides a "rapid and safe" method of accessing the circulation through the intra-osseous route, a technique that is being used by an increasing number of emergency care personnel for resuscitation and stabilization, which accesses the central circulation through blood vessels within the bone marrow that are held open by a rigid, non-collapsible bony wall.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze